Seminars in Thrombosis and Hemostasis

Article	Citations
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues	88
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	77
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis	56
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	53
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease	49
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review	44
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States	42
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis	37
Hemostasis from Bench to Bedside: The History of Three Successful Stories of Translational Medicine	36
	31
Erratum: Microparticles: An Alternative Explanation to the Behavior of Vascular Antiphospholipid Syndrome	29
Pregnancy Related Venous Thromboembolism-Associated with HIV Infection and Antiretroviral Therapy	27
Three-Dimensional Human Neural Stem Cell Models to Mimic Heparan Sulfate Proteoglycans and the Neural Niche	25
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	25
Mechanical Heart Valves, Pregnancy, and Bleeding: A Systematic Review and Meta-Analysis	24
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	24
Cardiovascular Oncology: The Need for a Multidisciplinary Approach	23
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic?	23
	22
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	22
Venous Thromboembolism Risk and Thromboprophylaxis in Pediatric Neurosurgery and Spinal Injury: Current Trends and Literature Review	21
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life	20
Response to “Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease”	20
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy	20
A Historical Perspective on the Reversal of Anticoagulants	19

Platelet-Type von Willebrand Disease: Complex Pathophysiology and Insights on Novel Therapeutic and Diagnostic Strategies	19
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications	19
Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders	19
Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders	19
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	19
Glanzmann Thrombasthenia 10 Years Later: Progress Made and Future Directions	19
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III	18
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting	18
	18
Altered Fibrinolysis during and after Surgery	18
The History of Factor XIII Deficiency	18
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization	18
Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients	18
The Role of CD36/GPIV in Platelet Biology	17
Dedication to Santa Maria Favaloro (1926–2022)	17
Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease	17
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome	16
Inhibitors of Polyphosphate and Neutrophil Extracellular Traps	15
Bleeding Scoring Systems in Neonates: A Systematic Review	15
Erratum: Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden	15
Russell Viper Venom: A Journey from the Bedside to the Bench and Back to the Bedside	15
Heparin: The Journey from Parenteral Agent to Nasal Delivery	14
What Role Does Microthrombosis Play in Long COVID?	14
Trousseau's Syndrome in 19th Century Qing Dynasty Paintings of Breast Tumors: Early Insights into Cancer and Thrombosis Risk	14
Editorial Compilation XIV	13
Effect of Heparanase and Heparan Sulfate Chains in Hemostasis	13
The Impact of Emotional Responses on Female Reproduction: Fibrinolysis in the Spotlight	13
The Role of Thromboelastography during the Management of Postpartum Hemorrhage: Background, Evidence, and Practical Application	13
Role of Platelets and Their Interaction with Immune Cells in Venous Thromboembolism	13
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part II	13
Mean Platelet Volume Predicts Severe COVID-19 Illness	13
Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk	13
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice	12
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies	12
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years	12
Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retr	12
Thromboembolic Complications in Takotsubo Cardiomyopathy	12
Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents	12
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases	12
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions	12
Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 versus Vaccine-induced Immune Thrombocytopenia and Thrombosis in the United Kingdom	11
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants	11
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook	11
Cerebral Venous Thrombosis	11
Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease	11
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis	11
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?	11
Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies	11
Reviewing the Rich History of Fibrin Clot Research with a Focus on Clinical Relevance	11
Novel Insights into Heterozygous Factor XIII Deficiency	11

Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review	11
Sticky Platelet Syndrome Revisited?	11
	10
The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either–or Proposition	10
Pharmacotherapy for Venous Thromboprophylaxis following Total Hip or Knee Arthroplasty: A Systematic Review and Network Meta-analysis	10
Fibrin Clot Properties in Cancer: Impact on Cancer-Associated Thrombosis	10
The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System	10
Catastrophic Thrombosis: A Narrative Review	10
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature	10
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years	9
Upper Extremity Deep Vein Thrombosis: Current Knowledge and Future Directions	9
Red Blood Cells in Thrombosis: Active Participants in Clot Formation and Stability: A Systematic Review	9
Substrates, Cofactors, and Cellular Targets of Coagulation Factor XIa	9
Is Vitamin D Deficiency Prothrombotic? A Systematic Review	9
Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes	9
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population	9
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy	9
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	9
Laboratory and Molecular Diagnosis of Factor XI Deficiency	9
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome	9
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis	9
Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients	9
Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?	8
Platelet Activation and Thrombosis in COVID-19	8
	8
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	8
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review	8
Venous Thromboembolism among Critically Ill Children: A Narrative Review	8
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease	8
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review	8
Factor XII Structure–Function Relationships	8
Recent Advances in Thrombosis and Hemostasis—Part VII	8
Gastrointestinal Bleeding in Congenital Bleeding Disorders	8
	8
	8
	8
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series	8
Platelet Function Testing: Update and Future Directions	8
The ART of Thromboprophylaxis in the Prevention of Gestational Venous Thromboembolism	8
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)	8
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	8
Development of Molecules Antagonizing Heparan Sulfate Proteoglycans	8
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	8
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19	7
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies	7
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	7
Arterial Thrombosis in Cancer Patients: An Update	7
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions	7
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment	7
Erratum: Septic Pulmonary Embolism. A Contemporary Profile	7
Inflammation and Coagulation in Neurologic and Psychiatric Disorders	7
Description of an In Vitro Platelet Function Analyzer—PFA-100™	7
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature	7
Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology	7
Hereditary Hemorrhagic Telangiectasia: On the Brink of a New Treatment Era?	7
Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage	7
Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part I	7
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation	7
Blood Rheology and Hemodynamics: Still Illuminating after 20 Years	6
Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Literature Review and Description of Local Case in a 3-Year-Old Chinese Girl	6
Development of a Coagulation Disorders Unit	6
The Role of Myeloid Cells in Thromboinflammatory Disease	6
Testing for Lupus Anticoagulants	6
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade	6
Whole Blood Viscosity and Cerebral Blood Flow in Acute Ischemic Stroke	6
	6
A Critical Reappraisal of the Bleeding Time	6
	6
Platelet Pathophysiology: Unexpected New Research Directions	6
	6
Platelet Physiology	6
Contraceptives and Thrombosis: An Intertwined Revolutionary Road	6
Heparin and Posttraumatic Stress Disorder	6
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice	6
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More	5
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	5
Clinical, Laboratory, and Molecular Characteristics of Inherited Vitamin K–Dependent Coagulation Factors Deficiency	5
The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness	5
Platelets: Physiology and Biochemistry	5
Blood Rheology and Hemodynamics	5

The Role of Fibrin(ogen) in Wound Healing and Infection Control	5
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	5
Interaction between Antiphospholipid Antibodies and Protein C Anticoagulant Pathway: A Narrative Review	5
2023 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	5
2025 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	5
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review	5
The Most Highly Downloaded Publications from Seminars in Thrombosis and Hemostasis: A Data Analysis 10 Years in the Making	5
Thrombophilia Screening: Not So Straightforward	5
Thrombin: A Pivotal Player in Hemostasis and Beyond	5
Clinical, Laboratory, Molecular, and Reproductive Aspects of Combined Deficiency of Factors V and VIII	5
Mutations Accounting for Congenital Fibrinogen Disorders: An Update	5
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia	5
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays	5
New Seminars in Thrombosis and Hemostasis 2022 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	5
Editorial Compilation XI	5
Precision Medicine in Rare Bleeding Disorders	5
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease	5
Rotational Thromboelastometry Predicts Transfusion Requirements in Total Joint Arthroplasties	5
VEXAS Syndrome and Thrombosis: Findings of Inflammation, Hypercoagulability, and Endothelial Dysfunction	5
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	5
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	5
The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice	5
ABO Blood Group and the Risk of Thrombosis in Cancer Patients: A Mini-Review	5
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	5
The Overlooked Risk of Venous Thromboembolism in Psychiatric Patients: Epidemiology, Pathophysiology, and Implications for Clinical Care	4
The Role of Platelets in Atherosclerosis: A Historical Review	4
The History of Rare Bleeding Disorders	4
Right Ventricular Recovery: Early and Late Changes after Acute PE Diagnosis	4
Role of Viscoelastic and Conventional Coagulation Tests for Management of Blood Product Replacement in the Bleeding Patient	4
Venous Thromboembolism among Noncritically Ill Hospitalized Children: Key Considerations for the Pediatric Hospital Medicine Specialist	4
2020 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	4
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	4
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	4
PKC-Delta-Dependent Pathways Contribute to the Exacerbation of the Platelet Activity in Crohn's Disease	4
Proposal for a Simple Algorithmic Approach to Manage Drug–Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients	4
Safety and Efficacy of Rivaroxaban for Inferior Vena Cava Thrombosis after Successful Catheter-Directed Thrombolysis	4
The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates	4
Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis	4
Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review	4
Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders	4
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism	4
Recent Advances in Thrombosis and Hemostasis—Part VIII	4
New Horizons in Fetal and Neonatal Alloimmune Thrombocytopenia	4
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings	4
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review	4
	4
Erratum: A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan	4
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature	4
The Fibrinolytic System in Peripartum Depression	4
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests?—Part II: The Use of Thromboelastography and Thromboelastometry in the Assessment of Clin	4
Low-Molecular-Weight Heparin Resistance and Its Viscoelastic Assessment in Critically Ill COVID-19 Patients	4
Prophylactic Treatment of Children with Hemophilia in Sweden	4
	4
	4
Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives	4
Cancer-Associated Splanchnic Vein Thrombosis	4
Hemostatic and Nonhemostatic Effects of Heparan Sulfate Proteoglycans	4
Venous Thromboembolism in Premature Neonates	4
	4
Pulmonary Embolism and Chronic Obstructive Pulmonary Disease	3
The Most Highly Cited Publications from Seminars in Thrombosis and Hemostasis: A Data Analysis 50 Years in the Making	3
Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease: Comment on “Cancers in Patients with von Willebrand Disease”	3
Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger	3
	3
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives	3
Hemostasis Testing in the Emergency Department: A Narrative Review	3
Letter to the Editor: 10-Year Evolution in Worldwide Usage of Anticoagulant Drugs	3
Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?	3
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?	3
Heterozygous ITGA2B Phe1024 Deletion Associated with Abnormal αIIbβ3 Function in a Patient with Congenital Thrombocytopenia	3
Von Willebrand Factor Multimer Analysis and Classification: A Comprehensive Review and Updates	3
Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants	3
Welcome to Seminars in Thrombosis & Hemostasis 2023	3
TEMPORARY REMOVAL: Factor inhibitor testing: An update from Australasia/Asia-Pacific	3
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L	3
Laser-Induced Blood Coagulation for Surgical Application: A Scoping Review	3
Innovative Therapies for Acquired Hemophilia A	3
Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice	3
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches	3
Association of Circulating Long Noncoding 7S RNA with Deep Vein Thrombosis	3
Fibrinolysis-Mediated Pathways in Acute Liver Injury	3
Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation	3
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	3
Editorial Compilation—XV	3
Editorial Compilation—XIII	3
Editorial Compilation XII	3
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure	3
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines	3
Recent Advances in Thrombosis and Hemostasis—Part X	3
Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review	3
Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond	3
Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy	3
Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography	3
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	3
Non-factor Therapies for Hemophilia: Achievements and Perspectives	3